Relapsing-remitting Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing-remitting Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)
A completed real-world study in Germany evaluated how ozanimod is used, its effectiveness, and quality of life in participants with relapsin…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis [Phase 1]
Phase 1 clinical trial evaluating the safety of ixazomib targeting plasma cells in relapsing-remitting and progressive multiple sclerosis; c…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS [Phase 4]
A Phase 4 clinical trial is evaluating early intensive versus escalation treatment strategies for relapsing-remitting multiple sclerosis and…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple Sclerosis [Phase 1]
Phase 1 clinical trial evaluating WEBCAMS, a walking exercise program, for brain and cognitive outcomes in adults with multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation [NA]
A clinical trial evaluating high-definition transcranial direct current stimulation to improve cognitive deficits in relapsing-remitting mul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis [Phase 3]
A Phase 3 non-inferiority trial comparing ocrelizumab with rituximab in active multiple sclerosis is described; the study is currently activ…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme [NA]
Completed clinical trial evaluating a computerised semi-autonomous at-home cognitive rehabilitation programme for people with relapsing-remi…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) [Phase 3]
Biogen's Phase 3 efficacy and safety study of BG00012 (dimethyl fumarate) in pediatric Relapsing-Remitting Multiple Sclerosis has completed.…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis [Phase 2]
Phase 2 study evaluating the effects of corticosteroids on asymptomatic gadolinium-enhancing lesions in Relapsing-Remitting Multiple Scleros…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis [Phase 1]
A Phase 1 trial evaluating peptide-coupled red blood cells for relapsing-remitting multiple sclerosis, sponsored by Cellerys AG, which is cu…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial (TOTEM) is evaluating testosterone treatment for neuroprotection and myelin repair in relapsing-remitting multiple …
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease [Phase 3]
Phase 3 clinical trial evaluating off-label ocrelizumab versus rituximab at onset of relapsing-remitting multiple sclerosis; currently activ…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis
A clinical trial is evaluating the effectiveness of combining a disease-modifying therapy with the Yishen Daluo Yin Modified Formula for rel…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial update evaluating the impact of cladribine tablets on central nervous system biomarkers in individuals with multiple …
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating bazedoxifene acetate as a remyelinating therapy for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Educational Kinesiology Program's Effect on Cognition, Manual Dexterity and Bimanual Coordination in MS Patients [NA]
A completed clinical trial update from Cairo University evaluating an Educational Kinesiology Program's effects on cognition, manual dexteri…
-
CLINICAL_TRIALS research · 2025-06-02Clinical Trial Update: Cladribine Tablets as an Exit Therapy Strategy
A clinical trial is evaluating cladribine tablets as an exit therapy strategy for multiple sclerosis, including relapsing-remitting and seco…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis [Phase 1]
Phase 1 clinical trial results for ANK-700 in relapsing-remitting multiple sclerosis have been posted.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
An ongoing IOBA-sponsored study is evaluating visual processing speed and objective ocular movement analysis in individuals with Multiple Sc…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC [NA]
The MultiSCRIPT-Cycle 1 study is a pragmatic platform trial embedded within the SMSC aimed at personalized medicine approaches for Relapsing…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Administration of Fingolimod in Greek Patients With Multiple Sclerosis.
Clinical trial update indicates Fingolimod is to be administered in Greek patients with Relapsing Remitting Multiple Sclerosis, with the stu…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: COMparison Between All immunoTherapies for Multiple Sclerosis.
A completed clinical trial led by Karolinska Institutet comparing all immunotherapies for relapsing-remitting multiple sclerosis has posted …
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
A clinical trial update reports reduced oligodendrocyte-specific cytotoxicity observed with Ofatumumab treatment in Relapsing Remitting Mult…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) [NA]
A completed clinical trial (RETIMUS) investigating the detection of retinal perivascular inflammation in multiple sclerosis patients using a…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration [Phase 2]
Phase 2 clinical trial evaluating intranasal methylprednisolone for acute relapses in Relapsing-Remitting Multiple Sclerosis. The study is c…